| August
4, 2011
SHS acquires
Spiegelberg.
SHS Gesellschaft für
Beteiligungsmanagement mbH (SHS), a growth investor in Tuebingen,
Germany, has acquired the corporate shares in Spiegelberg (GmbH
& Co.) KG (Spiegelberg). SHS and Spiegelberg announced this
today.
SHS Gesellschaft für
Beteiligungsmanagement, founded in Tübingen in 1993, offers
finance and advice for innovative companies in new industries, especially
in the healthcare and life sciences sectors. With their current
investment funds, SHS holds around 120 million euro of investment
capital. The chief partners are the former McKinsey consultants
Bernhard Schirmers and Reinhilde Spatscheck, and Hubertus Leonhardt,
former Corporate Finance Project Leader at Arthur Andersen. www.shsvc.net
...
read the press release
...
lesen Sie die Presseinformation

March
24, 2010
Final
results of SILVER study show a significantly lower infection rate
in the Silverline group.
Ms. Nicole Keong presented
the final results of the Silver Impregnated
Line Versus
EVD Randomised
Trial at the SBNS
spring meeting in Cambridge: Of a total of 278 patients, the
infection rate was 12.3% in the Silverline group, in the control
group it was 21.4% (p= 0.041 in a two tailed test). This is a statistically
significant reduction of the infection rate.
Now class I evidence is
available to show the reduction of infection by Silverline catheters.
...download
abstract
October
29, 2009
Spiegelberg
receives Award for Innovative Medical Technology from the German
Federal Ministry of Education and Reserach.
A consortium consisting
of Charité Berlin and Spiegelberg (GmbH & Co.) KG under
the leadership of Prof. Klaus Affeld was given the prestigious award
for the development of a new catheter that prevents access of bacteria
by means of a balloon which fills up the inside of the catheter.
The award was given to Klaus Affeld in a ceremony in Berlin.
...
more information about the award and about the project.

See
the award
September 21, 2009
Significant
reduction of infections with Silverline® Ventricular EVD-Catheters
In a study covering 231
patients Jens Fichtner and his co-authors of a full article in The
Journal of Neurosurgery demonstrated a significant reduction of
infections in the study group as compared to a sham group.
...download
abstract
...purchase
article
...download
thesis
September
18, 2009
New
Silverline® Lumbar Drainage Catheter and Subdural Drainage Catheter
launched internationally.
Silverline® Lumbar
Drainage Catheters help to fight the risk of infection in lumbar
drainage. Lumbar Drainage is used for perioperative CSF-drainage,
for diagnosis of Normal Pressure Hydrocephalus (NPH), and whenever
lumbar CSF-drainage is indicated for up to 30 days.
Silverline® Subdural
Drainage Catheters are indicated for drainage after evacuation of
Chronic Subdural Hematoma (CSH).
...more
information
November
26, 2008
Successful
treatment of infected shunt patients with Silverline catheters published.
Dr. Yusuf Izci and his
co-authors from the Gulhane Military Medical Academy in Ankara,
Turkey treated seven patients suffering from infected shunt systems.
Silverline catehters were used in all patients. Nove of them developed
a re-infection. Patients' ages were between six months and 53 years.
Mean follow up period was 14 months. This is a major success for
both the authors and the product.
...
download abstract
October
23, 2008
Spiegelberg
receives Award for Innovative Medical Technology from the German
Federal Ministry of Education and Reserach.
A consortium consisting
of Charité Berlin, Spiegelberg (GmbH & Co.) KG, and German
Heart Institute Berlin under the leadership of Prof. Klaus Affeld
was given the prestigious award for the development of a new method
for non-invasive blood pressure measurement. The award was given
to Klaus Affeld in a ceremony in Berlin.

Picture
of the ceremony.
...
more information about the award and about the project.

See
the award
September
5, 2008
Silverline
Ventricular Shunt-Catheter launched.
The CE-mark was given
to the Silverline Ventricular Shunt-Catheter as a permanent implant.
It is compatible with all shunt valves designed for 1.3 mm inner
diameter catheters.
...more
information can be found in the EVD and Shunt brochure.
August
1, 2008
Statistically
significant reduction of infection rate with Silverline EVD catheters
In a study in the University
of Innsbruck, Austria, a significantly lower infection rate was
observed in patients with acute occlusive hydrocephalus who had
received a Silverline catheter.
Download
abstract
June
16, 2008
ICP Lab
software launched.
ICP
Lab, a software tool for recording, browsing, storing, and
printing of ICP data was launched today.
ICP
Lab was written by Dr. Peter Smielewski in the University
of Cambridge. Tha data format is ICM+. I.e. data recorded
with ICP Lab can be further analyzed using the University
of Cambridge´s ICM+ software.
more...
|
|

|
March
1, 2008
The Argi
Group is our new distributor in Turkey. Argi will carry all the
Spiegelberg Silverline products.
November
15, 2007
Harburger
Rundschau reports very positively about the Spiegelberg Company.
In a full page article
the local paper reports about the Technology Park and about
Spiegelberg in particular.
Download
page.
November
1, 2007
Silverline
Catheters found to be effective against Streptococcus Intermedius.
Dipl.-Biol. Regina Zschaler
could demonstrate the effect of Silverline Catheters on Streptococcus
intermedius:
Download
report.
September
6, 2007
Results
of SILVER study close to significance.
Nicole Keong
and Peter Kirkpatrick presented results of the Silver
Impregnated Line
Versus EVD
Randomised Trial at the EANS
meeting in Glasgow: Of a total of 135 patients group A had an infection
rate of 20.8%, whereas group B had 7.9%.
Download
abstract.
September
3, 2007
Break
through for minimally invasive treatment of intracranial aneurysms.
APG Medical Ltd., a spin
off company of Forth Medical and Spiegelberg announces break through
for minimally invasive treatment of intracranial aneurysms.
The new Magseal method
involves steering a substance composed of magnetic nanoparticles
into the aneurysm by means of an external magnetic field. The substance
then seals the aneurysm and obliterates the condition.
In an in vivo proof of
concept study the method was found to be feasible and safe.
The study was presented
at the EANS
meeting in Glasgow on September 6, 2007.
Download
abstract.
Before
After Magseal procedure
What
the papers say:
English
translation
July
22, 2007
New family
of antimicrobial intraventricular probes launched
At the International ICP
Symposium in San Francisco Spiegelberg presented a new line of antiseptic
intraventricular probes. They are available for tunneling away from
the burr hole with a two way trocar, and for bolt fixation.
more...
February
2, 2007
Interim
results of SILVER study published
At the conference of the
British Neurosurgical Research Group in Manchester Nicole Keong
and Peter Kirkpatrick presented interim results of the Silver
Impregnated Line
Versus EVD
Randomised Trial. The infection rate
in one arm of the study is markedly lower than in the other arm.
more...
February
1, 2007
New distributor
in Pakistan
Spiegelberg Products are
now distributed in Pakistan by
Paramed
International
B-67 Ground Floor
Sha Faisal Town
Jinnah Avenue, Malir
Karachi
Pakistan
Email: paramedint@hotmail.com |
|
|
January
1, 2007
New distributor
for IAP-products in Germany
IAP-products are now distributed
in Germany by
Probe & go
Elsässer Str. 18
79346 Endingen
Tel.: 07642-928153
Fax.: 07642-928154
info@probe-go.de
January
1, 2007
Spiegelberg
ICP-products and EVD-products now distributed directly in all of
Germany
Orders from Hospitals
in Germany are now served directly from Hamburg. Günter Schwandner,
an independent agent, now works in the southern part of the country.
Günter Schwandner
mobile: 0043-699-1178-7961
December
1, 2006
Silverline
EVD-Catheter made of silicone now available
Made of implant grade
medical silicone, the new Silverline (TM) EVD-Catheter was given
the CE-mark Design Examination Certificate by the Notified Body.
It is available at the same price as the polyurethane Silverline
Catheter.
more...
November
1, 2006
Forth
Medical now carries Spiegelberg EVD-products and ICP-products
All the spiegelberg products
are now available from a single source in the UK and Ireland.
Forth Medical
Ltd.
42 Kingfisher Court
Hambridge Road
Newbury
Berkshire
Great Britain
Phone 0044-1635-550-100 |
|
|
April
1, 2006
New distributor
in the middle east
Spiegelberg products are
now distributed in Jordan, Saudi Arabia, Kuwait and the United Arab
Emirates by:
Ashy
Medical Company
Yafa Medical Compound
Kamal Junblat St.
Amman
Jordan
Phone 00962-659-37582/3
Email: Ashy@wanadoo.jo
|
|
|
November 20, 2005
Spiegelberg
certified according to DIN EN ISO 13485:2003
The DQS,
notified body no. 297, certified the production, sales, and R&D
of Spiegelberg according to DIN EN ISO 13485:2003. At the same time
the certificate according to Annex II of the Medical Devices Directive
93/42 EC and the EC Design-Examination Certificates were renewed.
August
26, 2005
New distributor
in Greece
As of October
1, 2005 KK Medical Specialist will be the new exclusive distributor
for all ICP-products and EVD-products.
KK Medical
Specialist
9, Mantzarou
str.
Neo Psychico
15451 Athens
Greece
Phone +30
210 6717009
Fax +30 210
6717004
E-mail kkatsamba@kkmedical.com
www.kkmedical.com

March 2005
Silverline
EVD-Catheters now available in both 8F and 10F sizes.
November
3, 2004
Innovation
award of the City of Hamburg given to Spiegelberg KG for the development
of Silverline Antimicrobial EVD-Catheters.
In a ceremony in the old "Handwerkskammer" the award was
given to Dr. Andreas Spiegelberg and his team.
See the award
What
the TV reported
What the papers say:

Read
the full article in Süderelbe Wochenblatt, January 5, 2005

Read the full article
in Hamburger Abendblatt
November
4, 2004, p. 26

Read the full article
in Harburger Anzeigen und Nachrichten,
November 4, 2004, p. 7
Read
the full article in Bild, November 4, 2004, p. 9
September 20, 2004
Silverline Antimicrobial EVD-Catheters could
demonstrate their effect in an in-vitro study.
Dipl.-Biol. Regina Zschaler could demonstrate the effect of Silverline
Catheters in a complete in-vitro study in a spectacular manner:
- Staph. aureus,
- Staph. epidermidis,
- Methicillin resistant Staphylococcus,
- E. coli,
- Pseudomonas aeruginosa,
- Candida albicans, and
- Candida glabrata
were eradicated
completely.
more...
September 15, 2004
Silverline Antimicrobial EVD-Catheter launched
in the United Kingdom.
The distributor for the Silverline Catheters in the United Kingdom
is
September 1, 2004
Silverline Antimicrobial EVD-Catheter launched
in France.
The distributor for the Silverline Catheters in France is
Laboratoire Schwallmed
Hans Schwall
10 les Grenadiers
83310 Grimaud
France
Tel.: 04 94 55 69 95
April 25, 2004
Silverline Antimicrobial EVD-Catheter launched
in Germany
The new product line of antimicrobial EVD-Catheters contains a patented
combination of antiseptic substances that do not generate resistancies
against antibiotics.
more...
|